2. Protein Tyrosine Kinase/RTK GPCR/G Protein
  3. Insulin Receptor GCGR
  4. Glybuzole

Glybuzole (Desaglybuzole) is an orally effective hypoglycemic agent. Glybuzole promotes insulin secretion by pancreatic β cells and inhibits glucagon secretion by pancreatic α cells. Glybuzole reduces blood glucose levels as well as arginine-stimulated plasma glucagon levels. Glybuzole can be used in diabetes-related research.

For research use only. We do not sell to patients.

Glybuzole

Glybuzole Chemical Structure

CAS No. : 1492-02-0

Size Price Stock
5 mg Ask For Quote & Lead Time
10 mg Ask For Quote & Lead Time
25 mg Ask For Quote & Lead Time
50 mg Ask For Quote & Lead Time
100 mg Ask For Quote & Lead Time

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Glybuzole Related Antibodies

Top Publications Citing Use of Products

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Glybuzole (Desaglybuzole) is an orally effective hypoglycemic agent. Glybuzole promotes insulin secretion by pancreatic β cells and inhibits glucagon secretion by pancreatic α cells. Glybuzole reduces blood glucose levels as well as arginine-stimulated plasma glucagon levels. Glybuzole can be used in diabetes-related research[1][2][3].

In Vitro

Glybuzole (4-40 μg/mL; 24 h) binds to human serum albumin (HSA) with a binding constant of 15.6 μM[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Glybuzole Related Antibodies
In Vivo

Glybuzole (100 mg; intra-arterial; over 10 minutes) in anesthetized mongrel dogs significantly reduces blood glucose, stimulates pancreatic insulin secretion, and suppresses pancreatic glucagon secretion[1].
Glybuzole (50-100 mg/kg; p.o.; single dose, 29 consecutive days) reduces blood glucose in normal male Wistar rats, with a plasma half-life of 7 hours after a single 50 mg/kg dose, and is primarily excreted in feces and bile[2].
Glybuzole (50 mg/kg; p.o.; single dose) has reduced blood glucose-lowering efficacy in male Wistar rats pretreated with phenobarbital, and its plasma half-life is shortened to 4.5 hours after a single 50 mg/kg dose[2].
Glybuzole (50 mg/kg; p.o.; single dose) has its plasma half-life prolonged to 28 hours after a single 50 mg/kg dose and results in sustained blood glucose reduction in male Wistar rats pretreated with SKF 525A[2].
Glybuzole (50 mg/kg; p.o.; single dose) has its plasma half-life prolonged to 34 hours after a single 50 mg/kg dose, increases urinary excretion 2.5-fold compared to normal rats, and results in sustained blood glucose reduction in male Wistar rats pretreated with Carbon tetrachloride (HY-Y0298)[2].
Glybuzole (20-100 mg/kg; p.o., i.v.; single dose) reduces blood glucose levels in normal male rabbits[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: mongrel (adult, 18-28 kg, anesthetized)[1]
Dosage: 100 mg
Administration: intra-arterial; over 10 minutes
Result: Decreased femoral artery blood glucose to 72.0 mg/100ml at 40 minutes post-infusion.
Increased pancreatic vein plasma insulin to 164.0 μU/mL at 1 minute and 352.3 μU/mL at 3 minutes post-infusion, then declined toward baseline by 40 minutes.
Decreased pancreatic vein plasma glucagon from baseline to a nadir of 0.92 mμg/mL at 6 minutes post-infusion, then returned to baseline.
Animal Model: Wistar (male, body weight 190-210 g)[2]
Dosage: 50 mg/kg (single dose); 100 mg/kg (29 consecutive daily doses followed by a single 100 mg/kg dose)
Administration: p.o.; single dose; 29 consecutive days
Result: Reached peak blood concentration of ≈100 μg/mL at 1 hour, with a plasma half-life of 7 hours after a single 50 mg/kg oral dose.
Excreted 20.6% of administered radioactivity in urine and 74.2% in feces over 96 hours; excreted 91.1% of administered radioactivity in bile within 48 hours after a single 50 mg/kg oral dose.
Accounted for 88.6-94.4% of plasma radioactivity as unchanged drug over 1-24 hours, with metabolites I and II making up 1.5-3.6% and 2.3-8.5% respectively after a single 50 mg/kg oral dose.
Accounted for 97.5-97.8% of plasma radioactivity as unchanged drug over 1-24 hours, with metabolites I and II making up 0.3-1.4% and 1.1-1.9% respectively after 30 days of continuous 100 mg/kg dosing.
Reduced blood glucose levels in normal rats, with the lowest levels observed at 1-3 hours post-administration after a single 50 mg/kg oral dose.
Animal Model: Wistar (male, body weight 190-210 g, pretreated with phenobarbital)[2]
Dosage: 50 mg/kg
Administration: p.o.; single dose
Result: Reached peak blood concentration at 1 hour, with a plasma half-life of 4.5 hours after a single 50 mg/kg oral dose.
Excreted 27.8% of administered radioactivity in urine over 96 hours after a single 50 mg/kg oral dose.
Accounted for 73.0-92.7% of plasma radioactivity as unchanged drug over 1-12 hours, with metabolite II increasing to 22.1% at 12 hours after a single 50 mg/kg oral dose.
Showed reduced blood glucose-lowering activity compared to normal rats after a single 50 mg/kg oral dose.
Animal Model: Wistar (male, body weight 190-210 g, pretreated with SKF 525A)[2]
Dosage: 50 mg/kg
Administration: p.o.; single dose
Result: Reached peak blood concentration at 3 hours, with a plasma half-life of 28 hours after a single 50 mg/kg oral dose.
Excreted 27.8% of administered radioactivity in urine and 71.6% in feces over 96 hours after a single 50 mg/kg oral dose.
Accounted for 93.9-99.9% of plasma radioactivity as unchanged drug over 1-24 hours, with minimal metabolites detected before 24 hours after a single 50 mg/kg oral dose.
Produced a sustained blood glucose-lowering effect in pretreated rats after a single 50 mg/kg oral dose.
Animal Model: Wistar (male, body weight 190-210 g, pretreated with carbon tetrachloride)[2]
Dosage: 50 mg/kg
Administration: p.o.; single dose
Result: Reached peak blood concentration at 3 hours, with a plasma half-life of 34 hours after a single 50 mg/kg oral dose.
Excreted 50% of administered radioactivity in urine and 36% in feces over 96 hours; excreted 66.3% of administered radioactivity in bile within 48 hours after a single 50 mg/kg oral dose.
Produced a sustained blood glucose-lowering effect in pretreated rats after a single 50 mg/kg oral dose.
Animal Model: (male, body weight 2.5 kg)[2]
Dosage: 20-100 mg/kg (20 mg/kg i.v.; 100 mg/kg p.o.)
Administration: p.o.; i.v.; single dose
Result: Reduced blood glucose levels in normal rabbits, with the lowest levels observed at 3 hours post-administration after a single 100 mg/kg oral dose.
Reduced blood glucose levels in normal rabbits, with the lowest levels observed at 2 hours post-administration after a single 20 mg/kg intravenous dose.
Molecular Weight

297.40

Formula

C12H15N3O2S2
CAS No.
SMILES

O=S(C1=CC=CC=C1)(NC2=NN=C(C(C)(C)C)S2)=O
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

Glybuzole Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Glybuzole1492-02-0DesaglybuzoleInsulin ReceptorGCGRGlucagon Receptorrabbitsglucagon secretionratsinsulin secretiondiabeteshuman serum albuminmongrel dogsmale Wistar ratspancreatic beta cellspancreatic alpha cellsInhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

  

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

      

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Glybuzole
Cat. No.:
HY-120401
Quantity:
MCE Japan Authorized Agent:

Customer Review

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Product Name

  

Lot #

Applicant Name *

 

Email Address *

Phone Number

 

Department *

Organization Name *

 

Country or Region *

Remarks

SAFETY DATA SHEET (SDS)

Request for HNMR Report

We have received your request and will respond to you as soon as possible.